Belgium· BE-AMP-SAM220035-00
Terazosab 1 mg
A terazosin product containing terazosin hydrochloride, registered in Belgium by Amdipharm. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Terazosin is registered in 12 of 19 countries.
Countries holding a registration under ATC G04CA03 (terazosin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Terazosin · ATC G04CA03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of terazosin costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in United States to $0.93 in Switzerland — a ×5.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Terazosin · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.93
- IT Italy$0.31
- US United States$0.19 (acquisition cost)
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Terazosin Hydrochloride
- Manufacturer
- Amdipharm
- Country
- Belgium (BE)
- ATC code
- G04CA03
- ATC class
- Terazosin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2103281
- be_apb0777128
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
186 interactions on record for terazosin.
Graded by severity as the source publishes them — 72 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Terazosin · interactions on record
186 records
- 72 moderate
- 1 minor
- 112 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Terazosin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesterazosinREMEDYREPACK INC.
- United KingdomBenph 2mg tabletsViatris UK Healthcare Ltd
- ItalyITRINEBERLIFE FARMACEUTICI S.P.A.
- SpainALFAPROST 5 mg COMPRIMIDOSBiowise Pharmaceuticals, S.L.
- CanadaAPO-TERAZOSINAPOTEX INC
- NetherlandsHytrin 10, tabletten 10 mgAmdipharm Limited
- FranceDYSALFA 1 mg, compriméAMDIPHARM
- NorwayHeitrinAmdipharm
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Uroflo, Vicard
- Czechia · Kornam
- Germany · Heitrin, Tera Tad
- Denmark · Sinalfa
- Spain · Alfaprost, Mayul
- France · Dysalfa, Hytrine
- United Kingdom (Northern Ireland) · Hytrin, Terazosin
- Greece · Hytrin
- Hungary · Setegis
- Ireland · Hytrin
- Italy · Itrin, Prostatil
- Luxembourg · Hytrin, Terazosab
- Netherlands · Hytrin, Terazosine Accord
- Norway · Sinalfa
- Poland · Hytrin, Kornam
- Portugal · Hytrin
- Sweden · Sinalfa
- Slovenia · Kornam
- Slovakia · Kornam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc7b4a35-ddd7-4731-acd9-62248ad3b0d0 GET /v1/drugs/fc7b4a35-ddd7-4731-acd9-62248ad3b0d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Terazosab 1 mg",
"name_fr": "Terazosab 1 mg",
"name_nl": "Terazosab 1 mg",
"amp_code": "SAM220035-00",
"strengths": [
"1.0000",
"128.5600"
],
"pack_count": 1,
"substances": [
"Terazosin Hydrochloride",
"Terazosin",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Terazosin",
"authorisation_numbers": [
"BE220035"
]
}See everything about terazosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.